First published online August 17, 2006
British Journal of Radiology (2006) 79, 991-998
© 2006 British Institute of Radiology
doi: 10.1259/bjr/10893584
The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using
-rays or reactor thermal neutrons
S Masunaga, MD, PhD
1
Y Sakurai, PhD
4
K Nagata, MD, PhD
1
M Suzuki, MD, PhD
1
A Maruhashi, PhD
2
Y Kinashi, MD, PhD
3
H Nagasawa, PhD
5
Y UTO, PhD
6
H Hori, PhD
6 and
K Ono, MD, PhD
1
1 Radiation Oncology Research Laboratory, 2 Division of Radiation Life Science, 3 Division of Radiation Safety, Research Reactor Institute, Kyoto University, Osaka, 4 Department of Physics, Faculty of Medicine, Sapporo Medical University, Sapporo, 5 Laboratory of Pharmaceutical Chemistry, Gifu Pharmaceutical University, Gifu, 6 Department of Biological Science and Technology, Faculty of Engineering, University of Tokushima, Tokushima, Japan

View larger version (36K):
[in this window]
[in a new window]
|
Figure 1. The clonogenic cell survival curves after -ray irradiation (left panel) or reactor thermal neutron beam irradiation (right panel) with conventional dose-rate irradiation (CDRI) or reduced dose-rate irradiation (RDRI) in combination with tirapazamine (TPZ) or without TPZ. TPZ was given as a single intraperitoneal injection (i.p.) or by continuous subcutaneously administration (cont.). Bars represent standard deviations.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Figure 2. The normalized micronucleus frequencies after -ray irradiation with conventional dose-rate irradiation (CDRI) or reduced dose-rate irradiation (RDRI) in combination with tirapazamine (TPZ) or without TPZ in the total (left panel) and Q (right panel) tumour cell populations. TPZ was given as a single intraperitoneal injection (i.p.) or by continuous subcutaneously administration (cont.). Bars represent standard deviations.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Figure 3. The normalized micronucleus frequencies after reactor thermal neutron beam irradiation with conventional dose-rate irradiation (CDRI) or reduced dose-rate irradiation (RDRI) in combination with or without tirapazamine (TPZ) administration in the total (left panel) and Q (right panel) tumour cell populations. TPZ was given as a single intraperitoneal injection (i.p.) or by continuous subcutaneously administration (cont.). Bars represent standard deviations.
|
|
Copyright © 2006 by the British Institute of Radiology.